Interactive Clinical Intelligence

Interactive Clinical Intelligence (ICI) was a specialized market research agency focused on the oncology sector, providing strategic insights to pharmaceutical and biotechnology companies. The firm was well-regarded for its "OncoReport" series, which offered detailed analysis of clinical trends, physician prescribing behaviors, and market dynamics in oncology. ICI was acquired by Medical Media Holdings (MMH) in the late 2000s and subsequently became part of the portfolio of Providence Equity Partners in 2013. Key leadership from the company went on to establish other prominent healthcare research and communications firms, including Cadence Communications & Research. The company's data and reports were frequently utilized in clinical and economic studies to evaluate the impact of diagnostic assays and therapeutic interventions.